Population pharmacodynamic analysis of hemoglobin A1c-lowering effects by adding treatment of DPP-4 inhibitors (sitagliptin) in type 2 diabetes mellitus patients based on electronic medical records.
Population pharmacodynamic analysis of hemoglobin A1c-lowering effects by adding treatment of DPP-4 inhibitors (sitagliptin) in type 2 diabetes mellitus patients based on electronic medical records.
复制标题
基于电子病历对 2 型糖尿病患者加用 DPP-4 抑制剂（西他列汀）降低血红蛋白 A1c 效果的群体药效学分析。
DOI：
10.1016/j.jdiacomp.2016.06.009
复制
发表时间：
2016
影响因子：
3
通讯作者：
Ichiro Ieiri
中科院分区：
文献类型：
--
作者：
Makoto Kakara;Hiroko Nomura;Mai Ezaki;Masato Fukae;Takeshi Hirota;Sunao Matsubayashi;Masaaki Hirakawa;Ichiro Ieiri
